BSE filing, NSE: ANURAS. Summary written from the filing by ALFA Finder's alert engine.
Anupam Rasayan India Ltd: key numbers
- Share price
- ₹1,154.00
- Market cap
- ₹13,138 Cr
- Revenue (annual)
- ₹2,365 Cr
- Net profit (annual)
- ₹170.1 Cr
- P/E (TTM)
- 75.2×Sector 34.5×
- Promoter holding
- 59.07%+0.00% QoQ
- FII holding
- 8.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anupam Rasayan India Ltd
All →Anupam Rasayan India Annual General Meeting
Anupam Rasayan India Limited filed copy of minutes of its Annual General Meeting held on September 30, 2026. The filing is procedural and carries no financial or business event.
Anupam Rasayan India Share Pledge
Catalyst Trusteeship Ltd, as Debenture Trustee, received pledge on 24,62,215 shares of Anupam Rasayan India. Encumbered stake rose from 14.90% to 17.07% of total capital.
Anupam Rasayan India Share Pledge
Promoter Mona Anandbhai Desai created and released pledges on shares securing ₹578 Crore subsidiary debt. Net 14,60,625 shares (1.28%) remain encumbered post-transactions.
- Value
- ₹578.0 Cr
Anupam Rasayan India Share Pledge
Anupam Rasayan India Ltd promoters Anand Sureshbhai Desai and Shraddha Anand Desai pledged 1,20,41,160 equity shares. The pledge serves as security for debt obligations and loans.
- Value
- ₹145.0 Cr
Anupam Rasayan India Acquisition
Anupam Rasayan corrected its previous disclosure regarding the acquisition of Bliss GVS Pharma Limited, clarifying the share counts acquired by the company and its PAC.
Anupam Rasayan India Annual General Meeting
Anupam Rasayan India Ltd held its 23rd Annual General Meeting on September 30, 2026, through video conferencing to approve financial and operational matters.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.